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Ankle Foot Orthoses for Young Children with Cerebral Palsy: a Scoping 
Review 
Abstract 
Aim: To describe research on outcomes associated with early Ankle Foot Orthosis (AFO) use, AFO use 
patterns, and parent and clinician perspectives on AFO use among young children with cerebral palsy. 
Method: Arksey and O’Malley’s five-stage method was used to conduct a scoping review. MEDLINE 
(Ovid), PubMed, CINAHL, Cochrane Database of Systematic Reviews, EMBASE, PEDro, Web of Science 
and Scopus were searched for studies evaluating AFO use with children under the age of six years. 
Descriptive information was extracted and outcomes categorized according to the International 
Classification of Functioning, Disability and Health (ICF). Quality assessments were conducted to evaluate 
methodological rigor. Results: Nineteen articles were included in the review; 14 focused on body functions 
and structures, seven on activity level outcomes and no studies addressed participation outcomes. 
Evaluations of the effects of AFOs on gross motor skills other than gait were limited. Overall, the body of 
evidence is comprised of methodologically weak studies with common threats to validity including 
inadequate descriptions of study protocols, AFO construction, and comparison interventions. Conclusion: 
Research evaluating the effects of AFOs on age-appropriate, functional outcomes including transitional 
movements, floor mobility and participation in early childhood settings is needed to inform practice 
regarding early orthotic prescription.  
 
 
 
 
 
Keywords: ankle foot orthoses, cerebral palsy, young children 
Word count: 4071, excluding the abstract and bibliography  
 3 
Introduction 
Cerebral Palsy (CP) affects the development of movement and posture [1] and is characterized by 
primary impairments including muscle tone abnormalities, muscle weakness, disturbed 
coordination and decreased selective motor control, all of which can lead to secondary 
impairments such as muscle and joint contractures, bony deformities and gait deviations [2]. These 
impairments can cause activity limitations throughout the lifespan [1], and while CP is a non-
progressive condition, secondary impairments can progress over time resulting in significant 
changes to motor function. Health care professionals aim to enhance functional abilities and 
participation of individuals with CP through a variety of strategies including some focused on the 
prevention of development of secondary impairments and optimizing efficiency of functional 
movement [3]. 
Ankle Foot Orthoses (AFOs) are frequently used with children with CP to prevent 
musculoskeletal deformities and to provide support and stability during standing and walking [4]. 
They are considered a mainstream treatment option and are often used in combination with other 
interventions to improve biomechanical alignment during gait. It is assumed that improved 
biomechanical alignment increases gait efficiency [5] and gait control [6-8]. For example, children 
with CP often present with spasticity in the gastrocnemius-soleus muscles and AFOs are used to 
control equinus position of the foot by limiting excessive ankle plantar flexion during gait [5, 9]. 
In addition to the biomechanical advantage of decreasing plantar flexion, AFOs may delay or 
prevent the alteration of the gastrocnemius musculotendinous unit architecture [10]. Multiple 
studies have suggested other positive, gait-related, biomechanical effects of AFOs with older 
children [9, 11, 12] including increased stride length [9, 11, 13-16], velocity [7, 13-17], and 
reduced energy expenditure [17-19]. The potential for adverse effects of long-term AFO use, 
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particularly those related to decreased gastrocnemius and soleus muscle strength have also been 
proposed [5].  
While gait-related outcomes associated with AFO use are important, the effects of AFOs 
on other gross motor skills, such as running, stair climbing, floor mobility [20], and participation 
in meaningful activities also require evaluation. A broad consideration of outcomes is particularly 
important for young children since orthoses are often prescribed before the age of six years [10], 
when they may prevent joint motion necessary for floor mobility and transitioning between 
positions on and off the floor. Since many young children with CP are still developing their motor 
skills [21], any devices perceived by parents to adversely affect movement, cause skin irritation, 
disuse atrophy, or movement limitations may offset suggested advantages of AFOs [22]. 
Therefore, in addition to understanding the effects of AFOs on outcomes, it is also imperative to 
have insight into the factors that influence AFO use in young children. Several reviews have 
addressed AFO use in children and youths with CP [6, 8, 12, 23, 24], however, none have focused 
on children under the age of six years. The overall aim of this scoping review was to describe the 
body of literature evaluating AFO use with young children with cerebral palsy.  
Methods 
Arksey & O’Malley’s five-stage process for scoping review studies [25] was used to conduct this 
review. While systematic reviews typically focus on articles with high level of evidence and 
quality to determine evidence to support specific outcomes of interest [25], scoping reviews 
describe existing research literature and highlight evidence gaps, thus representing a better fit with 
the review objectives. Although quality appraisal is not discussed in the framework presented by 
Arksey & O'Malley [25], incorporating the quality analysis for scoping studies has been 
recommended as a strategy for identifying methodological gaps [26, 27]. In keeping with these 
 5 
more recent recommendations, we also conducted a quality analysis to describe the level of 
evidence and quality of existing research. We adhered to the Preferred Reporting Items for 
Systematic reviews and Meta-Analysis Extension for Scoping Reviews (PRISMA-ScR) reporting 
guidelines [28].  
Stage 1: Identification of Research Questions  
The three research questions were: 1) What outcomes associated with early AFO use in young 
children with cerebral palsy have been evaluated? 2) What research has been conducted to describe 
AFO use patterns in young children with cerebral palsy? 3) What studies have explored parent and 
clinician perspectives on AFO use among young children with cerebral palsy? 
Stage 2: Identification of Relevant Studies  
Search strategies were developed in collaboration with a medical librarian, using the keywords 
“cerebral palsy” and “ankle foot orthosis.” The following eight databases were searched for 
relevant articles published until March 2018: MEDLINE (Ovid), PubMed, CINAHL, Cochrane 
Database of Systematic Reviews, EMBASE, PEDro, Web of Science and Scopus using database 
specific search queries. In addition, references in the selected articles were hand searched to ensure 
all relevant studies were identified. An example search strategy conducted in February 2018 is 
provided in Appendix A. 
Stage 3: Study Selection  
Inclusion criteria were original studies written in English that described outcomes associated with 
AFO use, AFO use patterns, or family and clinician experiences with AFO use with children with 
cerebral palsy under six years of age. Studies with a portion of participants six years and older 
were included if data for children under six years of age were extractable (e.g., case studies), or if 
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the sample included at least 50% of children younger than six years. Where it was not possible to 
determine the proportion of children under six years of age, studies with a mean age less than six 
were included. Conference abstracts, reviews and study protocols were excluded but were used to 
search for additional, relevant articles. Studies that evaluated AFOs in conjunction with other 
rehabilitation interventions were also excluded.   
Study selection was conducted in two phases according to the protocol outlined by Arksey & 
O’Malley [25]: 1) Titles and abstracts were reviewed and screened for relevance by one reviewer 
(PF). 2) Articles selected for full-text review were assessed independently by two reviewers (PF 
and LPW). The reviewers met to discuss discrepancies and to reach consensus on the articles to be 
included. The selection process is summarized in Figure 1.  
[Insert Figure 1 approximately here] 
Stage 4: Charting the Data  
The authors developed a data charting form to facilitate documentation. The form was pilot tested 
by two reviewers and modified to ensure relevant information was included. Data from the studies 
were charted independently by two reviewers (PF and LPW) and then discussed for the purpose 
of reaching consensus. General descriptive information about the study including authors, year 
and country of publication, study design, research objectives, participant information (i.e., age, CP 
sub-type, and Gross Motor Function Classification System (GMFCS) levels), interventions, and 
results were charted and tabulated. Outcomes evaluated were then classified using the conceptual 
framework of the International Classification of Functioning, Disability and Health (ICF) 
framework [29].  
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In order to consider methodological rigor of this body of research, level of evidence and 
quality of quantitative studies were assessed using the American Academy for Cerebral Palsy and 
Developmental Medicine (AACPDM) methodology for systematic reviews study conduct rating 
tool [30]. Consistent with the AACPDM methodology for systematic reviews, only group and 
single case design studies with level of evidence I-III were considered for quality appraisal [30]. 
The AACPDM group study conduct evaluation tool includes seven questions designed to detect 
threats to internal validity including adherence to inclusion/exclusion criteria and group 
assignment, assessor’s awareness of group assignment and adequate control for confounding 
variables. Group studies are classified as strong with a score of six or seven, moderate with a score 
of four or five and weak if the score is less than three. Single case design studies with a score of 
11-14 out of 14 questions are considered strong, seven to ten as moderate, and less than seven as 
weak quality [30]. Critical appraisal of qualitative research was conducted using the Joanna Briggs 
Institute (JBI) checklist for qualitative studies [31]. This tool is a ten-item checklist intended to 
evaluate rigor, with an emphasis on methodological cohesiveness. A score of ten indicates high 
quality. Independent raters (PF and LW) completed ratings for all included studies and then met 
to compare responses and reach consensus. Discrepancies (n=2 levels of evidence) were resolved 
by a third rater (LS).  
Stage 5: Summarizing and Reporting the Results  
Results are provided in Table 1. The 19 included studies were published between 1986 and 2018; 
the number of publications remained relatively consistent over time. The largest proportion of 
studies (n=8) were authored by researchers in the USA [32-39], followed by the UK (n=2) [40, 
41], Canada (n=2) [42, 43], China (n=2) [11, 44], South Korea (n=2) [45, 46], Egypt (n=1) [47], 
Iran (n=1) [48], and Belgium (n=1) [49] (Tables 1 & 2).  
 8 
 [Insert Table 1 approximately here] 
[Insert Table 2 approximately here] 
Study Design, Level of Evidence and Quality Assessment 
Of the 19 included articles, five were randomized controlled trials [32, 33, 44, 47, 48], including 
two randomized cross over design studies [32, 33]. In addition, there were three single-case design 
studies [37, 38, 41], three case-control studies [11, 39, 49], four case reports [34-36, 42], two 
cohort studies; one with a concurrent control group [46] and one without a control group [45], and 
a case series [40]. Only one qualitative study, an interpretive description, was identified and 
included [43].  
The AACPDM level of evidence and quality assessment ratings for group and single case 
design studies [30], are presented in Tables 1, 3 & 4. Of the 15 group design studies, one was level 
I [44], four were level II [32, 33, 47, 48], and one was level III [46]. The remaining nine studies 
were identified as level IV [11, 39, 40, 45, 49] and V [34-36, 42]. Of the three single case design 
studies, only one was level I [38], and the other two were classified as level IV [37, 41]. 
In our assessment of group studies, only the small randomized cross over design study 
(Level II) received a strong score [32]. Three studies were assessed as moderate [33, 44, 46], and 
two as weak quality [47, 48]. The only eligible single subject design for quality appraisal, the 
alternating treatment design, was determined to be of moderate quality [38]. 
The one included qualitative study [43] received a score of eight out of 10 (Table 5). A 
description of interventions, outcomes evaluated, and key findings are presented according to the 
three study objectives below.  
[Insert table 3 approximately here] 
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[Insert table 4 approximately here] 
[Insert table 5 approximately here] 
Outcomes Associated with AFO Use 
Seventeen studies evaluated outcomes associated with AFO use. These outcomes are reviewed and 
summarized according to the ICF dimensions (Table 6).   
Body Functions and Structures: Gait parameters including kinetics, kinematics and gait patterns 
(n=8) [11, 34, 35, 37, 40-42, 49], balance and stability (n=4) [38, 45-47], range of motion (n=8) 
[11, 34, 35, 37, 39, 41, 44, 49], and muscle activity with electromyography (EMG) (n=3) [11, 44, 
49], were the outcomes evaluated in the ICF Body Functions and Structures dimension. Only three 
of these studies were identified as level I-III of evidence [38, 46, 47] and the quality of these studies 
ranged from weak [47] to moderate [38, 46]. These three studies evaluated the effects of AFOs on 
standing balance [47], independent standing [38], postural stability and postural control 
mechanisms [46]. Positive effects of AFOs on independent standing [38], standing balance [47], 
and postural control mechanisms were reported [46].  
Activity and Participation: Outcomes evaluated in the ICF Activity domain included gross motor 
function as measured by the Gross Motor Function Measure (GMFM) (n=4) [32, 35, 36, 48], active 
time walking (n=1) [33], and motor strategies for sit-to-stand transition (n=1) [39]. Three of these 
studies were assessed as level II evidence, with quality ratings of weak [48], moderate [33], and 
strong [32]. Two of these studies reported positive effects of AFOs on gross motor skills (crawling, 
kneeling, etc.) [32], standing and walking abilities [48], while the authors of the moderate quality 
study did not report any improvement in community walking activity [33]. No studies included 
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evaluations of participation. Outcomes and outcome measures used in the included studies are 
classified by ICF dimensions and summarized in Table 6.  
[Insert Table 6 approximately here] 
AFO Characteristics: Six studies compared the effects of two different types of AFOs [11, 34, 39, 
42, 48, 49]. Three of these studies compared solid (rigid) with hinged AFOs [34, 42, 48]. All three 
studies reported improvements in gait and standing with hinged AFOs. However, the 
methodological quality varied among these studies; one was a level II with weak quality [48], and 
the other two were level V [34, 42]. Lam et al. [11] compared the effects of conventional (solid) 
and dynamic AFOs on gait and concluded that they have unique short-term effects; conventional 
(solid) AFOs increased the function of calf muscles and improved walking endurance while 
dynamic AFOs caused less ankle restriction and better management of equinus positioning of the 
foot [11]. Wilson et al. [39] evaluated articulated AFOs in locked and unlocked positions to 
determine the effect on sit-to-stand transfer time. The unlocked position decreased sit-to-stand 
time compared to the locked position [39]. The study that compared the effects of posterior leaf 
spring and dual carbon fiber spring AFOs on gait patterns demonstrated a greater improvement of 
ankle push-off with the latter AFO type [49]. However, all three studies [11, 39, 49] were classified 
as level IV evidence.  
Four studies compared the effects of different AFO types on walking activity in 
community-based settings [33], walking patterns [41], subtalar joint alignment during molding of 
AFOs [35], and compensatory gait strategies due to orthoses induced restrictions in joint 
movement [36]. One of these studies was identified as level II [33] and three were classified as 
level IV-V evidence [35, 36, 41]. While the studies with lower levels of evidence reported positive 
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effects of supramalleolar orthoses [35, 36], hinged [36, 41] and solid AFOs [35, 41], the study with 
level II evidence did not find any difference in either walking activity level (number steps/day & 
proportion of time walking) or intensity (number of strides/day & peak activity index) between 
supramalleolar orthosis, non-articulated, hinged, and solid AFOs [33].  
Seven articles focused on one type of AFO [32, 38, 40, 44-47], either dynamic [32], 
inhibitive [38], three-side support [47], solid [40] or hinged [44-46]. These studies included 
evaluations of the effects of day vs. day-night use [44], sit-to-stand transfer time [45], and postural 
stability and control mechanisms [46] using hinged AFOs, and the effects of solid AFOs on gait 
[40]. In addition, one study evaluated the effects of dynamic AFOs on gross motor skills [32], and 
the effects of inhibitive AFOs [38] or three-side support AFOs [47] on standing balance. Two of 
the seven studies were identified as level I (moderate quality) [38, 44], two as level II (one strong 
[32] and one weak quality [47]) and one study as level III evidence (moderate quality) [46]. The 
remaining two studies were identified as level IV evidence [40, 45]. All studies reported positive 
effects associated with AFO use.  
One study (level IV evidence) evaluated the effect of Neurodevelopmental Treatment 
(NDT) in isolation and in combination with inhibitive AFOs [37]. It was reported that NDT was 
more effective in isolation for decreasing knee flexion over time, but the combined method had 
better immediate effects on decreasing excessive knee flexion [37]. However, since the study was 
non-randomized single case design (low level of evidence) and was not replicated across more 
than one subject, inferences about effectiveness are limited. No long-term longitudinal studies 
were included in the review. A description of the AFOs evaluated in each study and key findings 
are presented in Table 1.  
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AFO Use Patterns in Young Children with CP 
Only one study addressed outcomes associated with AFO use patterns, a large RCT (level I, 
moderate quality) [44]. Zhao et al. [44], examined the effects of day vs. day-night use of hinged 
AFOs among young children with CP on gross motor skills, muscle activation (EMG), and passive 
ankle range of motion. There was an improvement in range of motion and GMFM scores after 
using AFOs for both day and day-night groups, but there was no difference in range of motion 
between the two groups. Also, GMFM scores were higher for the day wear group compared to the 
day-night wear group [44]. No studies describing actual AFO use patterns of young children were 
identified for inclusion in this review.  
Parent and Clinician Experience with AFO Use 
Only one study explored clinician experience with prescribing AFOs for children with CP. This 
qualitative study suggested that orthotic prescription is a dynamic process based on clinician 
assessment and collaboration of the rehabilitation team [43]. No studies about parent’s perspective 
and experience associated with their children’s AFO use were identified. 
Discussion 
This review confirmed a predominant focus on gait-related outcomes in research evaluating AFOs 
with young children with CP and revealed some gaps related to evaluating the effects on other age-
appropriate gross motor skills. While a previous review suggested that wearing AFOs might create 
challenges for daily routines and floor mobility of young children who have less developed motor 
skills [20], the effects of AFOs on these outcomes have not been evaluated. Clinicians often 
recommend limiting AFO wear time to certain hours when children wear shoes. This strategy could 
overcome movement restrictions caused by AFOs that affect floor mobility when children are not 
wearing shoes. However, shoe removal may not be appropriate for some community settings such 
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as preschools and daycares. In addition, adherence to limiting AFO wear time when shoes are on 
might not be an ideal strategy for younger children who spend a significant amount of time on the 
floor. Thus, additional research is required to evaluate the effects of AFOs on a broader range of 
age-appropriate gross motor skills and other meaningful outcomes including activities specific to 
young children who use different movement strategies, such as crawling and bottom shuffling to 
explore their environment. Furthermore, the effects of AFO-footwear combination tuning with 
younger children need to be evaluated. While one level IV study evaluated the effects of AFOs 
with shoes on/off in young children [49], none of the studies included evaluation of the effects of 
AFO-footwear combination tuning on functional outcomes with younger age groups. The effects 
of optimal AFO-footwear combination tuning on participation outcomes also requires attention 
since the main reason for providing AFOs is to improve walking function so that children can 
participate in the activities that are meaningful to them [50].  
We conducted a quality appraisal to allow a description of the methodological quality of 
this body of literature. The level of evidence and quality evaluations revealed a weak evidence 
base with few studies using rigorous research designs and strategies to avoid threats to validity. 
Absence of power calculations [32, 33, 46-48], unmasked assessors [46, 47], lack of clear 
descriptions of interventions [44, 49], and inclusion/exclusion criteria [47, 48] were common 
sources of potential biases among the level I-III studies evaluated. This finding is consistent with 
systematic reviews on AFO use by older children [6, 24]. While case studies can be valuable for 
highlighting novel approaches and previously unreported findings, lack of randomized, controlled 
trials or rigorous single subject designs limits the ability to make inferences about effectiveness 
and inform practice. Single subject and randomized, cross over designs may be feasible in clinical 
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settings as these designs allow for smaller sample sizes while still allowing for rigorous evaluations 
of the effects of AFOs.  
This review also revealed a lack of a standard terminology about AFO types, which makes 
comparison across studies challenging; a limitation identified in previous reviews [6, 20, 24, 51]. 
Ambiguity creates challenges with generalizability of the findings and valid comparisons across 
studies. Ridgewell et al. [12] suggested use of reporting guidelines for AFO interventions for 
children with CP, and emphasized the importance of reporting AFO design and material details to 
facilitate comparison of different types of AFOs and to facilitate study replication [12]. Despite 
these recommendations, a recent literature review by Eddison et al. [51] confirmed that studies 
evaluating AFOs for children with CP still lack adequate descriptions of AFO construction. 
Adherence to reporting guidelines would provide consistency, facilitate comparison of findings 
across studies, and enable the conduct of meta-analyses.  
The small number of articles included in our scoping review also highlighted the lack of 
studies focused on AFO use in children under the age of six. Assessing the effects of AFOs in 
natural environments, such as child care and community settings, may be an effective way to 
expand the evaluation of outcomes with this group of children and families. Evaluation of 
children’s functioning in their homes, schools, and communities would provide valuable 
contextual information relevant to participation; daily challenges that may not be apparent in 
controlled, clinical settings. While research with this younger age group can be more challenging 
[39, 52], the different position transitions, variety of mobility methods, and potential for unique 
parent’s perspectives on AFO use necessitate evaluations specific to this age group.  
We identified only one study exploring clinicians’ perspectives about AFO prescription for 
children with CP [43], and we found an absence of studies about parent experience. Kane et al. 
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[43], aimed to identify underlying patterns associated with clinical AFO prescription. 
Collaboration of rehabilitation team members and evaluation of AFO outcomes were presented as 
influential factors in decision making in regards to AFO prescription [43]. However, these factors 
could be affected by inexperienced individual clinicians, possibly resulting in children not 
receiving the optimal orthoses type. This insight into clinical practice highlights the value of 
qualitative research that elucidates the subjective experiences of clinicians that affect how they 
approach AFO prescription and consultation with families.  
AFO use often declines after the age of five [10], and therefore, longitudinal research to 
explore use patterns and challenges associated with AFO use is also warranted. A qualitative study 
conducted with parents of children between 4-18 years [53] (not included in this review) suggested 
that parents perceived dynamic AFOs had positive effects on posture and alignment, and 
psychosocial factors such as participation in play and peer activities [53]. Research exploring 
parent perspectives would also be valuable for informing clinical practice as parent and child 
experience with AFO use in daily life will likely affect how much and where they decided to use 
them. Qualitative research with parents also has the potential to inform prescription guidelines for 
younger children as setting meaningful goals for AFO use is an important consideration during the 
prescription process [23]. Gaining insight into parent’s perspective and experience may also assist 
with the development of family-centered guidelines for wear time recommendations, ideal age or 
stage of development for prescription, as well as providing the basis for discussion about the 
activities that may be affected by AFOs.  
Finally, there were no longitudinal studies included in our review. While we were likely to 
exclude those that evaluated older children or adults, this gap has been noted previously [8, 20]. 
Longitudinal study designs would provide additional information about the long-term effects of 
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AFO use, including possible contributions to muscle weakness, effects on the development of 
contractures and associated long-term effects on activity and participation level outcomes.  
Limitation & Future Research Directions 
Since we limited the search to children under six years, we may have excluded longitudinal studies 
that included some data for younger children.  
Findings of this scoping review highlight the need for more rigorous research evaluating 
the effects of AFOs on activity and participation level outcomes for children with CP. In particular, 
the evidence base would benefit from studies with more rigorous methodologies, more detailed 
information about AFO design and parallel interventions, and additional qualitative studies to 
explore perspectives of parents regarding AFO prescription and use. A broader perspective on 
outcomes, in addition to evaluating the effects of AFOs on gait, would be beneficial. For example, 
studies with young children could include the effects of AFOs on floor mobility, transitional 
movements, and participation in age-appropriate play. Addressing these evidence gaps could 
inform evidence-based protocols for prescribing AFOs for young children with CP. 
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Appendix A. Search Strategy for Medline (Ovid) Database. 
1. exp Foot Orthoses/ 
2. ((ankle-foot) adj2 (orthos$ or orthotic$ or brace$ or splint$ or support$)).mp 
3. ((ankle or foot) adj2 (orthos$ or orthotic$ or brace$ or splint$ or support$)).mp 
4. ((lower-limb$) adj2 (orthos$ or orthotic$ or brace$ or splint$ or support$)).mp. 
5. ((lower extremit$) adj2 (Orthos$ or Orthotic$ or Splint$ or brace$ or support$)) 
6. exp Orthotic Devices/ 
7. exp Braces/ 
8. 6 OR 7 
9. exp Ankle Joint/ or exp Ankle/ 
10. exp Foot/ or exp Foot Joints/ 
11. 9 OR 10 
12. 8 AND 11 
13. exp Lower Extremity/ 
14. 13 AND 8 
15. 1 OR 2 OR 3 OR 4 OR 5 OR 12 OR 14 
16. exp Cerebral Palsy/ 
17. (Cerebral Pals$).mp. 
18. 16 OR 17 
19. 15 AND 18 
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Table 1.Quantitative Study Description 
Author Country Participants* Study Design, 
& Level-
Quality** 
Aim/Purpose of Study Intervention(s) Key findings 
Bjornson et 
al. (2006) 
[32] 
USA n=23,  
1 year 9 months - 7 years 
3 months,  
spastic,  
GMFCS I (n=6), II (n=3) 
& III (n=14)  
Randomized 
cross-over 
design, II- S 
(6/7) 
To examine the immediate 
effect of bilateral dynamic 
AFOs on crawling, 
kneeling, standing, walking, 
running and jumping skills.   
Dynamic AFOs Dynamic AFOs improved gross motor 
skills in a clinical setting. 
Bjornson et 
al. (2016) 
[33]  
USA n=11,  
3 - 6 years old,  
bilateral CP,  
GMFCS I (n=1), 
II (n=9) & III (n=1) 
  
Randomized 
cross-over 
design, II- M 
(4/7) 
To examine the effects of 
AFOs on walking activity in 
the community  
All participants wore 
prescribed orthoses 
(supramalleolar orthosis,  
non-articulated, hinged & 
solid AFOs) or no 
orthoses for two weeks in 
random order 
AFO/footwear did not affect number 
steps/day, % time walking, number of 
strides/day >30 strides/min & peak 
activity index. 
Butler et al. 
(1992) [40]  
UK n=6,  
3 years 7 months - 6 
years 5 months,  
hemiplegia (n=1), 
diplegia (n=5),  
GMFCS NR 
 
Case series, IV To examine the effects of 
adjusted, solid AFO use and 
balance training with 
children with CP 
Solid AFOs with passive 
stretching of ankle 
dorsiflexion, balance 
training of 10-15 minutes 
for 4-6 months 
Decreased magnitude of knee-
extension moment arm toward normal 
occurred when barefoot. Improvement 
was noted for knee-extension 
moments, foot/ground contact and 
stance phase posture. Improvements 
were not related to range of motion or 
speed. 
Carmick 
(1995) [34] 
USA n=1,  
18 months,  
spastic diplegia,  
GMFCS NR; the 
participant was 
ambulatory 
Case report, V NR Solid and then hinged 
AFOs with physical 
therapy once a week to 
increase ankle range of 
motion 
Hinged AFOs allowed more ankle and 
forefoot mobility which led to 
biomechanical gait changes. They also 
were associated with improved 
balance, strong heel strike and less 
internal rotation of legs. 
Carmick 
(2012) [35] 
USA n=4,  
Case 3: 4 years,  spastic 
diplegia 
Case 4: 3 years 5 months,  
ataxia & hypotonia  
Both  GMFCS III (Cases 
1 & 2 excluded based on 
age) 
Case report, V To illustrate the importance 
of subtalar joint alignment 
during casting for an 
orthotic device.  
Solid AFO & 
supramalleolar orthosis 
Molding orthosis in a position other 
than the neutral position of the 
subtalar joint had detrimental impacts 
on lower limb joints alignment which 
contributed to gait deviation, pressure 
sores and inability to walk. 
Carmick 
(2013) [36] 
USA n=3,  
Case 1: 4 years,  spastic 
diplegia, GMFCS II 
Case report, V To illustrate compensation 
strategies while wearing 
AFOs  
Hinged AFO &  
supramalleolar orthosis 
with electrical stimulation  
Internal hip rotation and toe walking 
occurred when orthoses blocked digit 
extension. 
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Case 2: 6 years, spastic  
quadriplegia, GMFCS II 
Case 3: 4 years 11 
months, spastic diplegia 
GMFCS III 
Dalvand et 
al. (2013) 
[48] 
Iran I: n=20, C: n=10, 
4 - 8 years old, spastic 
diplegia, GMFCS I 
(n=12), II (n=13) & III 
(n=5) 
Randomized 
controlled trial, 
II- W (2/7) 
To examine the effects of 
hinged and solid AFOs on 
standing and walking 
abilities  
NDT for 3 months (3, 1 
hour sessions/week) with 
hinged or solid AFOs for 
the intervention groups 
and barefoot for the 
control group 
Hinged AFOs improved standing and 
walking. 
Desloovere 
et al. (2006) 
[49] 
Belgium I: n=15,  
4 - 10 years,  spastic 
hemiplegia, GMFCS NR 
C: n=51 (historical TD 
controls),  
3 to 11 years 
Case-control 
study, IV 
To evaluate the effects of 
two types of orthoses on 
gait in a homogeneous 
group of children, using 
both barefoot and shoe 
walking as a control 
condition.  
Posterior leaf spring & 
dual carbon fiber spring 
AFOs combined with 
shoes for the intervention 
group.  
Both AFOs improved gait patterns, 
however, push-off at the ankle 
improved significantly with the carbon 
fiber spring AFO.  
Combination of both orthoses and 
shoes were necessary for improving 
spatiotemporal parameters of gait. 
Embrey et 
al. (1990) 
[37] 
USA n=1,  
2 years 8 months,  
spastic diplegia,  
GMFCS NR; the 
participant ambulated 
independently 
Single subject 
design (A-B-A-
BC-A), IV 
To examine the 
effectiveness of inhibitive 
ankle-height orthoses used 
in conjunction with NDT 
and effectiveness of NDT in 
isolation to decrease 
excessive knee flexion 
during gait.  
Bilateral inhibitive AFOs 
with NDT (30-minute 
session, 3 times per week 
for 3 months) 
The use of NDT alone was more 
effective than the combination of NDT 
and AFOs. However, the combination 
had a more immediate effect on 
excessive knee flexion during gait. 
Hainsworth 
et al. (1997) 
[41] 
UK n=12,  
3 years 11 months - 7 
years 5 months,  
spastic diplegia (n=8) & 
spastic hemiplegia (n=4), 
GMFCS NR; all children 
were ambulatory 
Single subject 
design (ABAB), 
IV  
To examine the effects of 
AFOs on walking patterns  
Hinged & solid AFOs 
with routine 
physiotherapy 
AFOs improved joint range of 
movement and gait (mediolateral shear 
force).   
Harris & 
Riffle 
(1986) [38] 
USA n=1,  
4 years 5 months,  
spastic quadriplegia, 
GMFCS NR; the 
participant could sit, 
knee-walk, pull-to-stand 
by half-kneeling over the 
right foot and stand 
independently for 10 
seconds without orthoses 
Single subject 
design 
(alternating 
treatment),  I-M 
(9/14) 
To examine the effects of 
inhibitive AFOs on 
independent standing  
Inhibitive AFOs AFOs improved the duration and 
maintenance of standing balance as 
well as standing pattern symmetry.  
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Lam et al. 
(2005) [11] 
China I: n= 13,  
3 years 3 months - 9 
years 7 months,  
spastic diplegia with 
moderate dynamic 
equinus, GMFCS NR 
C: n=18 , 
age: NR 
 
 
Case-control 
study, IV  
To examine the effects of 
different orthotics on gait  
Conventional (solid) & 
dynamic AFOs for the 
Intervention group. 
Control group was 
assessed barefoot 
Both AFOs were associated with 
increased stride length, better control 
of equinus and limited plantarflexion 
at push off. However, plantar flexion 
limitation at push-off was lesser with 
dynamic AFOs. Conventional AFOs 
reduced the median frequency of 
muscle firing which may result in 
improved walking endurance.  
Ankle movement was less restricted 
with dynamic AFOs.   
Middleton et 
al. (1988) 
[42] 
Canada n=1, 4 years 5 months, 
spastic diplegia, 
GMFCS NR 
Case report, V To evaluate the effects of 
rigid & hinged AFOs on 
gait by using quantitative 
biomechanical techniques. 
Hinged & rigid AFOs More natural ankle motion, lower knee 
moment during stance phase and 
enhanced lower limb symmetry 
occurred with hinged AFOs compared 
to rigid AFOs.   
Olama et al. 
(2013) [47] 
Egypt I: n=15  
Mean age (SD)= 4.8 
(0.77) years,   
spastic diplegia, GMFCS 
NR; all subjects could 
stand with support 
C: n= 15, 
Mean age (SD)= 4.4 
(0.69) years,  
spastic diplegia, GMFCS 
NR; all subjects could 
stand with support 
Randomized 
controlled trial, 
II- W (3/7) 
To evaluate the effects of 
three-side support AFOs on 
standing balance  
Three-side support AFOs 
(30-min session, three 
times weekly, for 6 
months) with therapeutic 
exercise for the 
intervention group. 
Control group received a 
therapeutic program only.  
Practicing with three side support 
AFO for 6 months, had positive effects 
on balance control and postural 
reactions. 
Park et al. 
(2004) [45] 
South 
Korea 
I: n=19, 
2 - 6 years,  
spastic diplegia,  
GMFCS NR; all 
participants could stand 
up from a chair 
independently 
C: n=21 ( historical TD 
controls),  
3-5 years 
Cohort study 
without a 
concurrent 
control group, 
IV 
To investigate the effects of 
hinged AFOs on sit-to-stand 
transfers  
Hinged AFOs Hinged AFOs improved temporal, 
kinetic and kinematic parameters of 
sit-to-stand transfers. 
Rha et al. 
(2010) [46] 
South 
Korea 
I: n=21 
Mean age (SD)= 6.10 
(1.09) years, 
all with spastic bilateral 
CP, GMFCS I (n=4), II 
(n=13) & III (n=4) 
Cohort study 
with a 
concurrent 
control group, 
III- M (5/7)  
To compare postural 
stability and control 
mechanisms during quiet 
side by side standing 
between typically 
developing children and 
Hinged AFO for the 
intervention group. 
Control group was 
assessed barefoot.  
Hinged AFO did not improve postural 
stability in quiet side-by-side standing. 
They were assisted with postural 
control.  
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*Participant: number, age, groups; control & intervention, CP sub-type and GMFCS levels.  
**Strong (S) = a score of 6 or 7, Moderate (M) = a score of 4 or 5, Weak (W) = a score of  3 
Abbreviations: I= Intervention group, C= Control group, GMFCS= Gross Motor Function Classification System, NR= Not Reported, AFO= Ankle Foot Orthoses, CP= Cerebral Palsy, NDT= Neuro 
Developmental Treatment, TD= Typically Developing, SD= Standard Deviation, NES= Neuromuscular Electrical Stimulation.  
 
Table 2. Qualitative Study Description 
Author Methodology Method 
Phenomena of 
Interest 
Setting  Participants 
Data 
Analysis 
Themes 
Kane et 
al. (2018) 
[43] 
Interpretive 
description 
Semi-
structured, in-
person focus 
groups 
AFO prescription and 
clinical decision-
making practices of 
clinicians 
Five rehabilitation 
centers in four 
Canadian provinces 
Four physiatrists, 17 
physiotherapists, 10 orthotists 
and one kinesiologist, 
(experience ranging from 1-39 
years) 
Comparative 
analysis 
AFO prescription is a 
collaborative, iterative 
and individualized 
process. 
 
 
C: n= 22,  
Mean age (SD)= 5.64 
(0.49) years, TD controls 
bilateral CP and to 
determine if hinged AFOs 
have any effects on 
improving the postural 
stability and control 
mechanisms in children 
with CP   
Wilson et al. 
(1997) [39] 
USA I: n=15  
2 -5 years, 
spastic diplegia with 
dynamic equinus,  
GMFCS NR; children 
could sit on a bench or 
stand up from a bench 
unsupported or by using 
a pole. 
C: n=20 , 
age: NR 
Case-control 
Study, IV 
To evaluate the effects of 
solid and articulated AFOs 
on sit-to-stand. 
Articulated AFOs in 
locked and unlocked 
positions (intervention 
group) compared to 
barefoot (control). 
Articulated AFOs in the unlocked 
position improved control of equinus 
and efficiency of sit-to-stand transfers. 
Zhao et al. 
(2013) [44] 
China Day group: n=56, 
Day-Night group: n=56, 
13 months - 4 years, 
spastic diplegia,  
GMFCS I (n=48) & II 
(n=64)  
Randomized 
controlled trial,  
I- M (5/7) 
To compare day vs day and 
night wear of hinged AFOs  
Hinged AFOs with 
conventional 
physiotherapy including 
NDT, hydrotherapy and 
NES for quadriceps 5 
times/week. 
No difference between groups 
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Table 3. Group Design Studies Conduct Rating Summary 
Author Study Design Level/Quality* 
In
clu
sio
n
/E
x
clu
sio
n
 
C
riteria
 
In
terv
en
tio
n
 D
escrip
tio
n
 
R
elia
b
le O
u
tco
m
e 
M
ea
su
res 
B
lin
d
ed
 A
ssesso
rs 
P
o
w
er C
a
lcu
la
tio
n
 
D
ro
p
o
u
t/ L
o
ss to
 
F
o
llo
w
-u
p
 
C
o
n
tro
llin
g
 B
ia
s 
Bjornson et al. (2006) [32] Randomized Cross-Over Design II- S (6/7) Yes Yes Yes Yes No Yes Yes 
Bjornson et al. (2016) [33]  Randomized Cross-Over Design II- M (4/7) Yes Yes Yes No No Yes No 
Dalvand et al. (2013) [48] Randomized Controlled Trial, (small RCT, n <100) II- W (2/7) No No Yes Yes No No No 
Olama et al. (2013) [47] Randomized Controlled Trial (small RCT, n <100) II- W (3/7) No Yes Yes No No No Yes 
Rha et al. (2010) [46] Cohort Study with Concurrent Control Group  III- M (5/7) Yes Yes Yes No No Yes Yes 
Zhao et al. (2013) [44]  Randomized Controlled Trial, (large RCT, n >100 ) I- M (5/7) Yes No No Yes Yes Yes Yes 
*Strong (S) = a score of 6 or 7, Moderate (M) = a score of 4 or 5, Weak (W) = a score of  3. 
 
Table 4. Single Subject Design Conduct Rating Summary 
A
u
th
o
r 
Study Design Level/Quality 
P
a
rticip
a
n
ts’ ch
a
ra
cteristics 
In
d
ep
en
d
en
t V
a
ria
b
le 
In
terv
en
tio
n
 D
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tio
n
 
D
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t V
a
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le
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ility
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S
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b
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 o
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a
ta
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e o
f S
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g
le S
u
b
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esig
n
 
A
d
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u
a
te N
u
m
b
er o
f D
a
ta
 P
o
in
ts 
R
ep
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tio
n
 o
f In
terv
en
tio
n
 a
cro
ss 
≥
 3
  
V
isu
a
l A
n
a
ly
sis 
G
ra
p
h
 fo
r V
isu
a
l A
n
a
ly
sis 
R
ep
o
rt o
f S
ta
tistica
l A
n
a
ly
sis 
C
riteria
 fo
r S
ta
tistica
l A
n
a
ly
sis 
Harris & Riffle (1986) [38] Alternating Treatment Design I-M (9/14) Yes No No Yes Yes No Yes Yes Yes No Yes Yes No Yes 
*Strong (S) = a score of 11-14, Moderate (M) = a score of 7-10, Weak (W) = a score of < 7. 
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Table 5. Critical Appraisal Checklist for Qualitative Research 
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Kane et 
al. 
(2018) 
[43] 
Yes Yes Yes Yes Yes No No Yes Yes Yes 
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Table 6. ICF Classification of Outcome Measures 
ICF Dimensions 
Outcomes Outcome Measures Author(s) 
B
o
d
y
 F
u
n
ct
io
n
s 
&
 S
tr
u
ct
u
re
s 
Balance & 
Stability 
Dynamic balance & biodex stability evaluation Olama et al. (2013) [47] 
Pressure data, anteroposterior (AP) & mediolateral (ML) 
displacement, transverse body rotation strategies 
Rha et al. (2010) [46] 
Duration of standing balance and independent standing Harris & Riffle (1986) [38] 
Temporal, kinetic and kinematic data during sit to stand 
transfer 
Park et al. (2004) [45] 
Gait 
Parameters 
Gait kinematics and kinetics Lam et al. (2005) [11], Embrey et al. (1990) [37], Butler et al. (1992) 
[40], Middleton et al. (1988) [42], Desloovere et al. (2006) [49]  
Gait pattern Hainsworth et al. (1997) [41] 
Gait description Carmick (1995) [34], Carmick (2012) [35] 
Muscle 
Activity 
Electromyography  Lam et al. (2005) [11], Zhao et al. (2013) [44], Desloovere et al. (2006) 
[49] 
Lower 
Extremities 
Range of 
Motion 
Active ankle dorsiflexion Lam et al. (2005) [11], Carmick (1995) [34], Desloovere et al. (2006) 
[49]  
Active knee flexion  Embrey et al. (1990) [37] 
Passive ankle dorsiflexion Wilson et al. (1997) [39], Hainsworth et al. (1997) [41], Zhao et al. 
(2013) [44]  
Passive knee and hip range of motion Wilson et al. (1997) [39]  
Active knee and hip range of motion Lam et al. (2005) [11], Desloovere et al. (2006) [49] 
Anatomical description of lower extremities Carmick (2012) [35] 
A
ct
iv
it
y
 
Gross Motor 
Function 
GMFM-88 Bjornson et al. (2006) [32] (sections C, D and E), Dalvand et al. (2013) 
[48] (sections D and E) 
GMFM-66  Bjornson et al. (2006) [32], Carmick (2012) [35], Carmick (2013) [36], 
Zhao et al. (2013) [44] 
Total daily steps & active walking time Bjornson et al. (2016) [33] 
Documentation of sit-to-stand strategies, sit to stand 
duration  
Wilson et al. (1997) [39] 
Participation  No studies that evaluated outcomes in the participation 
dimension were identified.  
 
Abbreviation: ICF= International Classification of Functioning, Disability & Health, GMFM= Gross Motor Function Measurement.
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Figure 1. PRISMA Flow Chart [54] 
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Additional records identified through 
other sources  
(n= 1) 
Records screened based on titles 
 (n=1252) 
Records screened based on 
abstracts (n= 242) 
Records excluded (n= 1010) 
Full-text articles assessed for 
eligibility  
(n= 157) 
Articles excluded based on 
age (n= 86), article format 
(i.e., reviews, reports and 
conference proceedings) (n= 
32) & lack of full article 
availability (n= 20) Studies included 
(n= 19) 
Duplicates (n= 1038) 
Records excluded (n= 85) 
